Format
Sort by
Items per page

Send to

Choose Destination

Best matches for AFP and Carcinoma, Hepatocellular:

Search results

Items: 1 to 20 of 5274

1.

MR molecular imaging of HCC employing a regulated ferritin gene carried by a modified polycation vector.

Zhang Q, Lu Y, Xu X, Li S, Du Y, Yu R.

Int J Nanomedicine. 2019 May 2;14:3189-3201. doi: 10.2147/IJN.S191270. eCollection 2019.

PMID:
31118631
2.

Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.

Kang YK, Choi JY, Paeng JC, Kim YI, Kwon HW, Cheon GJ, Suh KS, Kwon CHD, Lee DS, Kang KW.

Eur Radiol. 2019 May 21. doi: 10.1007/s00330-019-06239-z. [Epub ahead of print]

PMID:
31115626
3.

Prognostic Value of PD-L1 in Patients with Hepatocellular Carcinoma.

Pei R, Zhang W, Wang S, Huang X, Zou Y.

Clin Lab. 2019 May 1;65(5). doi: 10.7754/Clin.Lab.2018.180839.

PMID:
31115210
4.

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection.

Liu H, Chen H, Wu X, Sun Y, Wang Y, Zeng Y, Chen G, Liu X, Xing X, Zhao B, Liu J.

Cancer Manag Res. 2019 Apr 10;11:2935-2946. doi: 10.2147/CMAR.S190561. eCollection 2019.

5.

[Clinical significance of RYBP expression in primary hepatocellular carcinoma].

Jing X, Cai W, Huang B, Chen H, Chen D.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Apr 28;44(4):399-405. doi: 10.11817/j.issn.1672-7347.2019.04.009. Chinese.

6.

Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.

Xu D, Su C, Sun L, Gao Y, Li Y.

Ann Hepatol. 2019 Jan - Feb;18(1):58-67. doi: 10.5604/01.3001.0012.7863.

7.

Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center.

Kuftinec GN, Levy R, Kieffer DA, Medici V.

Ann Hepatol. 2019 Jan - Feb;18(1):177-186. doi: 10.5604/01.3001.0012.7910.

8.

A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma.

Luo CL, Rong Y, Chen H, Zhang WW, Wu L, Wei D, Wei XQ, Mei LJ, Wang FB.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819846632. doi: 10.1177/1533033819846632.

PMID:
31106685
9.

Biological characteristics of heat shock protein 90 in human liver cancer cells.

Qin L, Huang H, Huang J, Wang G, Huang J, Wu X, Li J, Yi W, Liu L, Huang D.

Am J Transl Res. 2019 Apr 15;11(4):2477-2483. eCollection 2019.

10.

Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.

Young SH, Chau GY, Lee IC, Yeh YC, Chao Y, Huo TI, Su CW, Lin HC, Hou MC, Lee MH, Huang YH.

J Formos Med Assoc. 2019 May 16. pii: S0929-6646(18)30891-X. doi: 10.1016/j.jfma.2019.04.018. [Epub ahead of print]

11.

Reply (to LTE HEP-19-0464).

Mehta N, Dodge JL, Yao FY.

Hepatology. 2019 May 16. doi: 10.1002/hep.30767. [Epub ahead of print]

PMID:
31095762
12.

Local regional therapy before liver transplantation for hepatocellular carcinoma.

Jiang N, Li X, Xing YF, Qiao YD, Chen J.

Hepatology. 2019 May 15. doi: 10.1002/hep.30769. [Epub ahead of print]

PMID:
31090941
13.

Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.

Zhang Z, Jiang H, Chen J, Wei Y, Cao L, Ye Z, Li X, Ma L, Song B.

Cancer Imaging. 2019 May 14;19(1):22. doi: 10.1186/s40644-019-0209-5.

14.

Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats.

Saleem S, Kazmi I, Ahmad A, Abuzinadah MF, Samkari A, Alkrathy HM, Khan R.

Nutr Cancer. 2019 May 15:1-12. doi: 10.1080/01635581.2019.1614199. [Epub ahead of print]

PMID:
31088230
15.

Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.

Sun P, Li Y, Chang L, Tian X.

Medicine (Baltimore). 2019 May;98(19):e15603. doi: 10.1097/MD.0000000000015603.

16.

Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.

Xiao J, Long F, Peng T, Hu LB, Cai H, Chen R, Chen WL.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3302-3310. doi: 10.26355/eurrev_201904_17692.

17.

Clinical significance of HDAC9 in hepatocellular carcinoma.

Hu Y, Sun L, Tao S, Dai M, Wang Y, Li Y, Wu J.

Cell Mol Biol (Noisy-le-grand). 2019 Apr 30;65(4):23-28.

PMID:
31078148
18.

Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.

Kim KH, Park GW, Jeong JE, Ji ES, An HJ, Kim JY, Yoo JS.

Anal Bioanal Chem. 2019 May;411(14):3009-3019. doi: 10.1007/s00216-019-01775-5. Epub 2019 May 11.

PMID:
31076819
19.

Serum sphingosine negatively correlates with albumin predicting the risk of hepatocellular carcinoma.

Huang K, Li W, Xiao J, Luo D, Jin J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Apr 17. doi: 10.5507/bp.2019.015. [Epub ahead of print]

PMID:
31074463
20.

Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma.

Chen Y, Li S, Li W, Yang R, Zhang X, Ye Y, Yu J, Ye L, Tang W.

Sci Rep. 2019 May 8;9(1):7084. doi: 10.1038/s41598-019-43572-1.

Supplemental Content

Loading ...
Support Center